APOE and hypertriglyceridemia: We therefore examined the data of a previously published randomized double-blind placebo-controlled dose-ranging phase 2 study of the effects of volanesorsen in patients with hypertriglyceridemia according to the distribution of APOE isoforms among patients (21).